Clinical trial
Multi-omics Study (Biological Therapy Followed by Immunotherapy) in Patients With Severe Asthma Due to Olive Pollen Allergy
NCT07721376 is registered in ClinicalTrials.gov with Maimónides Biomedical Research Institute of Córdoba as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-omics Study (Biological Therapy Followed by Immunotherapy) in Patients With Severe Asthma Due to Olive Pollen Allergy
- Lead sponsor
- Maimónides Biomedical Research Institute of Córdoba
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- October 28, 2024
- Completion date
- November 30, 2029
- Enrollment
- 18 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
allergy and asthma, pollen; allergy, asthma, severe asthma